GSK to acquire biopharmaceutical company Aiolos Bio for $1.4bn
The acquisition expands GSK’s respiratory pipeline with AIO-001, a phase 2-ready, long-acting antibody targeting the clinically validated TSLP…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jan 24
The acquisition expands GSK’s respiratory pipeline with AIO-001, a phase 2-ready, long-acting antibody targeting the clinically validated TSLP…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Jan 24
The Danaher-IGI Beacon for CRISPR Cures centre will use CRISPR-based gene editing technology to drive pre-clinical gene-editing therapies…
09 Jan 24
Through the acquisition, Johnson & Johnson will benefit from Ambrx’s portfolio of clinical and preclinical programmes, including lead…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jan 24
The collaboration is aimed at deepening comprehension of cell morphology, ultimately hastening the integration of AI-driven cellular analysis…
09 Jan 24
EU health regulator has approved the combination for adult patients with metastatic castration-resistant prostate cancer (mCRPC) in whom…
09 Jan 24
Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand
08 Jan 24
In addition to the acquisition of SanReno, Novartis has secured the US FDA approval for commercial manufacturing of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
08 Jan 24
The products covered by the agreement are Ascendis Pharma's Skytrofa (lonapegsomatropin), a weekly injectable paediatric human growth hormone…
08 Jan 24
Both companies will work together to study potential vaccines for bacterial pathogens in AstraZeneca’s early Vaccines & Immune…
05 Jan 24
The latest partnership, which is the second research strategic collaboration between Boehringer Ingelheim and 3T, will leverage Boehringer…